Bilateral acute depigmentation of the iris (BADI) and bilateral acute iris transillumination (BAIT): A case series from a center in Brazil
2023

Case Series on Iris Depigmentation and Transillumination

Sample size: 5 publication Evidence: low

Author Information

Author(s): Flavia Veiga Costa, Amanda Gomes e Silva, Leticia Alcântara Pedroso, Ana Luiza Biancardi, André Luiz Curi

Primary Institution: Instituto Nacional de Infectologia, Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brazil

Hypothesis

Can moxifloxacin use trigger iris depigmentation and transillumination in patients?

Conclusion

The study suggests that moxifloxacin may trigger iris depigmentation and transillumination, particularly in patients with recent COVID-19.

Supporting Evidence

  • All five patients experienced acute onset of bilateral pain and redness of the eyes after moxifloxacin use.
  • Four patients used oral moxifloxacin, while one used it topically.
  • Three patients had elevated intraocular pressure during their first visit.

Takeaway

This study looked at five women who had eye problems after using a medicine called moxifloxacin, which might be linked to their symptoms.

Methodology

The study involved a retrospective review of medical records from a tertiary uveitis center, focusing on patients diagnosed with BADI or BAIT.

Limitations

The study is limited by its small sample size and retrospective design.

Participant Demographics

All participants were female with a mean age of 41 years.

Digital Object Identifier (DOI)

10.5935/0004-2749.2023-0219

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication